Supernus Pharmaceuticals Inc (SUPN) Q2 2019 Earnings Call Transcript
SUPN earnings call for the period ending June 30, 2019.
Supernus Pharmaceuticals
SUPN
SUPN
$26.65
$0.98
3.8%
BATS BZX Real Time Price as of October 21, 2019, 4:00 p.m. EDT
View Interactive SUPN Charts
Supernus Pharmaceuticals Inc specialty pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system or CNS diseases.
News & Analysis: Supernus Pharmaceuticals
3 Top Value Stocks to Buy in May
Deep-value stocks like Supernus Pharmaceuticals and Party City look attractive now.
Supernus Pharmaceuticals Inc (SUPN) Q1 2019 Earnings Call Transcript
SUPN earnings call for the period ending March 24, 2019.
2 Incredibly Cheap Value Stocks to Buy Now
Exelixis and Supernus Pharmaceuticals are deeply undervalued healthcare plays.
Supernus Pharmaceuticals Inc (SUPN) Q4 2018 Earnings Conference Call Transcript
SUPN earnings call for the period ending December 31, 2018.
3 Top Small-Cap Stocks to Buy Right Now
Think software-as-a-service, neurology drugs, and marijuana.
3 Top Biotech Stocks to Buy in December
Find out why our healthcare contributors believe that these biotechs are great buys right now.
Here's Why Supernus Pharmaceuticals Is Sinking Today
Sometimes good news just isn't good enough.
3 Top Biotech Stocks to Buy in November
If you don't consider adding these biotech stocks to your portfolio this month, you could wind up missing out on an opportunity.
3 Top Biotech Stocks to Buy in September
These three relatively small biotechs could be just the ticket.
